GlassScriptPhysician profile
Jose Romano
NPI 1952321069
$10,964.95
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $148 · 2021: $9,000 · 2022: $1,155 · 2023: $164 · 2024: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $9,000.00 | 2021 | |
| Medical Device Business Services, INC. | $1,154.93 | 2022 | |
| Janssen Pharmaceuticals, INC | $150.48 | 2019-2020 | |
| Penumbra, INC. | $142.39 | 2023 | Red 72 |
| Genentech USA, INC. | $125.30 | 2019 | |
| Amgen INC. | $113.24 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $93.91 | 2019-2020 | |
| Argenx US, INC. | $92.76 | 2024 | Vyvgart |
| Microtransponder, INC. | $31.23 | 2024 | |
| Depuy Synthes Sales INC. | $23.26 | 2020 | |
| Abbvie INC. | $21.53 | 2023 | Botox |
| Medtronic USA, INC. | $15.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Romano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.